Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation
Open Access
- 8 November 2010
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 207 (12), 2675-2687
- https://doi.org/10.1084/jem.20091573
Abstract
In myeloid dendritic cells (mDCs), TLR3 is expressed in the endosomal membrane and interacts with the adaptor toll/interleukin 1 receptor homology domain–containing adaptor molecule 1 (TICAM-1; TRIF). TICAM-1 signals culminate in interferon (IFN) regulatory factor (IRF) 3 activation. Co-culture of mDC pretreated with the TLR3 ligand polyI:C and natural killer (NK) cells resulted in NK cell activation. This activation was triggered by cell-to-cell contact but not cytokines. Using expression profiling and gain/loss-of-function analyses of mDC genes, we tried to identify a TICAM-1–inducing membrane protein that participates in mDC-mediated NK activation. Of the nine candidates screened, one contained a tetraspanin-like sequence and satisfied the screening criteria. The protein, referred to as IRF-3–dependent NK-activating molecule (INAM), functioned in both the mDC and NK cell to facilitate NK activation. In the mDC, TICAM-1, IFN promoter stimulator 1, and IRF-3, but not IRF-7, were required for mDC-mediated NK activation. INAM was minimally expressed on NK cells, was up-regulated in response to polyI:C, and contributed to mDC–NK reciprocal activation via its cytoplasmic tail, which was crucial for the activation signal in NK cells. Adoptive transfer of INAM-expressing mDCs into mice implanted with NK-sensitive tumors caused NK-mediated tumor regression. We identify a new pathway for mDC–NK contact-mediated NK activation that is governed by a TLR signal-derived membrane molecule.Keywords
This publication has 52 references indexed in Scilit:
- The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK ActivationPLOS ONE, 2010
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansThe Journal of Experimental Medicine, 2009
- No Association between CALHM1 and Alzheimer's Disease RiskCell, 2008
- A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease RiskCell, 2008
- NK cell survival mediated through the regulatory synapse with human DCs requires IL-15RαJCI Insight, 2007
- Tumor immunotherapy using bone marrow‐derived dendritic cells overexpressing Toll‐like receptor adaptorsFEBS Letters, 2007
- Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cellsProceedings of the National Academy of Sciences, 2007
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumorin vivoProceedings of the National Academy of Sciences, 2001
- Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in MiceImmunity, 2000